Shares of DaVita HealthCare Partners Inc. (NYSE:DVA) traded down 4.1% during mid-day trading on Tuesday . The stock traded as low as $72.15 and last traded at $72.30, with a volume of 2,102,137 shares traded. The stock had previously closed at $75.36.

Several analysts recently issued reports on the stock. JPMorgan Chase & Co. reiterated a “hold” rating and set a $75.00 price target (up previously from $74.00) on shares of DaVita HealthCare Partners in a research report on Tuesday. Zacks Investment Research lowered shares of DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, July 27th. Wells Fargo & Co. reiterated a “buy” rating on shares of DaVita HealthCare Partners in a research report on Saturday, June 4th. Robert W. Baird reiterated a “buy” rating on shares of DaVita HealthCare Partners in a research report on Sunday, May 8th. Finally, TheStreet upgraded shares of DaVita HealthCare Partners from a “hold” rating to a “buy” rating in a research report on Wednesday, May 4th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company’s stock. DaVita HealthCare Partners presently has an average rating of “Hold” and an average price target of $78.00.

The firm has a market capitalization of $14.93 billion and a PE ratio of 32.44. The stock’s 50-day moving average is $76.76 and its 200-day moving average is $73.17.

DaVita HealthCare Partners (NYSE:DVA) last posted its quarterly earnings results on Monday, August 8th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.03. The business earned $3.72 billion during the quarter, compared to the consensus estimate of $3.67 billion. During the same period last year, the firm earned $0.95 EPS. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. On average, analysts forecast that DaVita HealthCare Partners Inc. will post $3.95 EPS for the current fiscal year.

In related news, CEO Dennis Kogod sold 17,700 shares of the company’s stock in a transaction that occurred on Tuesday, May 17th. The shares were sold at an average price of $77.35, for a total transaction of $1,369,095.00. Following the sale, the chief executive officer now owns 18,766 shares of the company’s stock, valued at approximately $1,451,550.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Roger Valine sold 8,220 shares of the company’s stock in a transaction that occurred on Thursday, May 12th. The stock was sold at an average price of $76.34, for a total transaction of $627,514.80. Following the sale, the director now directly owns 18,324 shares in the company, valued at approximately $1,398,854.16. The disclosure for this sale can be found here.

A number of hedge funds have recently bought and sold shares of the company. Advantus Capital Management Inc raised its stake in DaVita HealthCare Partners by 0.6% in the fourth quarter. Advantus Capital Management Inc now owns 15,975 shares of the company’s stock worth $1,114,000 after buying an additional 92 shares during the period. I.G. Investment Management LTD. raised its stake in DaVita HealthCare Partners by 28.4% in the fourth quarter. I.G. Investment Management LTD. now owns 17,802 shares of the company’s stock worth $1,241,000 after buying an additional 3,939 shares during the period. Pittenger & Anderson Inc. raised its stake in DaVita HealthCare Partners by 93.2% in the fourth quarter. Pittenger & Anderson Inc. now owns 29,360 shares of the company’s stock worth $2,047,000 after buying an additional 14,160 shares during the period. Utah Retirement Systems raised its stake in DaVita HealthCare Partners by 0.3% in the fourth quarter. Utah Retirement Systems now owns 31,618 shares of the company’s stock worth $2,204,000 after buying an additional 100 shares during the period. Finally, KBC Group NV raised its stake in DaVita HealthCare Partners by 82.7% in the fourth quarter. KBC Group NV now owns 35,965 shares of the company’s stock worth $2,507,000 after buying an additional 16,281 shares during the period.

DaVita HealthCare Partners Inc is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. Its segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. Its Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.